Mar 26, 2024 / 08:30PM GMT
Operator
Good afternoon and thank you for standing by. Welcome to Kane Biotech's fourth quarter and full year 2023 earnings conference call. During today's presentation, all parties will be in a listen only mode following the presentation, the conference call will be open to questions. (Operator Instructions) This conference is being recorded today, March 26, 2024. I would like to turn the conference call over to Ray Dupuis Kane Biotech's Chief Financial Officer. Please go ahead.
Raymond Dupuis - Kane Biotech Inc - Chief Financial Officer
Thank you, operator. Good afternoon, and welcome, everyone to Kane Biotech's fourth quarter and full year 2023 earnings conference call. We are delighted to have you join us today. This call will cover key financial and operating results, along with a discussion of some of our recent highlights and goals for 2024 and beyond. Following our prepared remarks, we will open the conference call to a question-and-answer session. Our call today will be led by Kane's Chief Executive Officer, Marc Edwards.
Before we begin our formal
Q4 2023 Kane Biotech Inc Earnings Call Transcript
Mar 27, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers